General Information of Drug (ID: DM8SY60)

Drug Name
Butoconazole Drug Info
Synonyms
Butaconazole; Butoconazol; Butoconazolum; Femstat; Gynofort; Duplicate RN for parent cpd; RS 35887; Butoconazol [INN-Spanish]; Butoconazole (INN); Butoconazole [INN:BAN]; Butoconazolum [INN-Latin]; Gynofort (TN); RS 35887-10-3; (+-)-1-[4-(4-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]-1H-imidazole; (+/-)-1-[4-(p-Chlorophenyl)-2-[(2,6-dichlorophenyl)thio]butyl]imidazole; (-)-1-((4-(p-Chlorophenyl)-2-((2,6-dichlorophenyl)thio)imidazole; 1-(4-(4-Chlorophenyl)-2-(2,6-dichlorophenylthio)-n-butyl)-1H-imidazole; 1-[4-(4-chlorophenyl)-2-(2,6-dichlorophenyl)sulfanylbutyl]imidazole; 1-{4-(4-chlorophenyl)-2-[(2,6-dichlorophenyl)sulfanyl]butyl}-1H-imidazole; 1H-Imidazole; 1H-Imidazole, 1-(4-(4-chlorophenyl)-2-((2,6-dichlorophenyl)thio)butyl)-, nitrate
Therapeutic ClassAntifungal Agents
Cross-matching ID
PubChem CID
47472
ChEBI ID
CHEMBL3240
CAS Number
CAS 64872-76-0
TTD Drug ID
D0N3SP

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Steroid biosynthesis 2.46 0.00e+0 19/20 (95%) DHCR7;LSS;TM7SF2;...
Ribosome 2.21 0.00e+0 113/158 (71.52%) RPS5;MRPS16;RPS16;...
Oxidative phosphorylation 2.17 3.50e-3 93/133 (69.92%) CYC1;NDUFA4;ATP5PF;...
Glycolysis / Gluconeogenesis 2.11 5.25e-3 56/67 (83.58%) GAPDH;DLD;ADH1B;...
Citrate cycle (TCA cycle) 2.08 4.20e-3 30/30 (100%) DLD;PCK1;ACLY;...
Thermogenesis 2.07 3.50e-3 173/232 (74.57%) GNAS;PLIN1;CYC1;...
Propanoate metabolism 1.99 6.01e-3 30/34 (88.24%) DLD;ACAT2;PCCB;...
Biosynthesis of unsaturated fatty acids 1.98 5.25e-3 21/27 (77.78%) SCD;HACD1;FADS2;...
Pyruvate metabolism 1.94 7.01e-3 41/47 (87.23%) DLD;ADH1B;PCK1;...
Terpenoid backbone biosynthesis 1.91 6.31e-3 18/22 (81.82%) DHDDS;ACAT2;FDPS;...
PPAR signaling pathway 1.84 1.53e-2 66/74 (89.19%) FABP4;SCD;LPL;...
Valine, leucine and isoleucine degradation 1.83 1.58e-2 42/48 (87.5%) DLD;ALDH1B1;ACAT2;...
Steroid hormone biosynthesis 1.75 2.51e-2 43/61 (70.49%) AKR1C2;UGT2B17;AKR1C1;...
Aminoacyl-tRNA biosynthesis 1.71 3.15e-2 15/66 (22.73%) IARS2;GATC;FARSA;...
One carbon pool by folate 1.70 3.15e-2 15/20 (75%) GART;MTHFD1;SHMT1;...
Cysteine and methionine metabolism 1.69 3.15e-2 43/50 (86%) CBS;PSAT1;APIP;...
Vibrio cholerae infection 1.67 3.71e-2 44/50 (88%) GNAS;CFTR;ACTB;...
Fanconi anemia pathway 1.65 3.97e-2 36/54 (66.67%) REV1;MLH1;FAAP100;...
N-Glycan biosynthesis 1.64 4.26e-2 38/50 (76%) MGAT4B;ALG5;MAN2A1;...
Mineral absorption -2.25 0.00e+0 48/60 (80%) HMOX1;ATP1B3;ATP1B2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Osteosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
U-2 OS CVCL_0042 Homo sapiens 4uM 6H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 0.04uM - 10uM 6H, 24H
Cervix
Cervical adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HeLa CVCL_0030 Homo sapiens 0.01uM - 10uM 3H, 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HT-29 CVCL_0320 Homo sapiens 0.01uM - 10uM 6H, 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
ASC CVCL_U602 Homo sapiens 10uM 24H
Kidney
Normal (Immortalized)
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HA1E CVCL_0284 Homo sapiens 0.01uM - 10uM 6H, 24H
Liver
Hepatoblastoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
Hep G2 CVCL_0027 Homo sapiens 10uM 6H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A549 CVCL_0023 Homo sapiens 0.01uM - 10uM 6H, 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HCC515 CVCL_5134 Homo sapiens 10uM 6H, 24H
Pancreas
Pancreatic carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
YAPC CVCL_1791 Homo sapiens 0.01uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 0.01uM - 10uM 6H, 24H
VCaP CVCL_2235 Homo sapiens 10uM 6H, 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-375 CVCL_0132 Homo sapiens 0.01uM - 10uM 6H, 24H